BRIEF published on 11/07/2025 at 07:33, 27 days 22 hours ago Fabasoft AG Reports Revenue and Earnings Growth in H1 2025/2026 Revenue Growth Recurring Revenue Fabasoft AG Market Strategies 2025/2026 Earnings
PRESS RELEASE published on 11/07/2025 at 07:28, 27 days 22 hours ago Fabasoft AG: Fabasoft increases revenue and earnings in the first half of 2025/2026 Fabasoft AG increases revenue and earnings in the first half of 2025/2026 fiscal year, with EBITDA at EUR 11.1 million and EBIT at EUR 7.3 million Revenue Financial Report Earnings Fabasoft AG 2025/2026
BRIEF published on 09/23/2025 at 18:53, 2 months 11 days ago Fabasoft AG Initiates Share Buyback Program Share Buyback Treasury Shares Stock Exchange Fabasoft AG EU Regulation
BRIEF published on 09/23/2025 at 18:53, 2 months 11 days ago Fabasoft AG Initiates Share Buyback Program Share Buyback Treasury Shares Stock Exchange Fabasoft AG Austrian Stock Corporation Act
PRESS RELEASE published on 09/23/2025 at 18:48, 2 months 11 days ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback Fabasoft AG resolves share buyback with approval of Supervisory Board to acquire treasury shares up to EUR 2,000,000.00, starting on 25 September 2025 Share Buyback Treasury Shares Stock Exchange Supervisory Board Fabasoft AG
PRESS RELEASE published on 09/23/2025 at 18:48, 2 months 11 days ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback Fabasoft AG resolves share buyback. The company plans to acquire treasury shares up to EUR 2 million, about 1.2% of its share capital. The buyback program is to start on 25 September 2025 Share Buyback Treasury Shares Fabasoft AG EUR 2 Million XETRA Closing Price
BRIEF published on 08/08/2025 at 07:44, 3 months 27 days ago Fabasoft Reports Growth in Revenue and Earnings for Q1 2025/2026 EBITDA Revenue Growth Fabasoft AG Investments Q1 2025/2026
PRESS RELEASE published on 08/08/2025 at 07:39, 3 months 27 days ago Fabasoft with revenue and earnings growth in the first quarter of 2025/2026 Fabasoft AG reports revenue and earnings growth of 3.7% in Q1 2025/2026, achieving EBITDA of EUR 4.3 million. Investments in Fabasphere and cloud-native software contribute to increased figures Revenue Growth Earnings Growth Fabasoft AG Investments Cloud-native Software Q1 2025/2026
BRIEF published on 06/10/2025 at 07:33, 5 months 24 days ago Fabasoft AG Reports Sustainable Growth in Fiscal Year 2024/2025 Revenue Increase Fiscal Year 2025 Fabasoft Growth Cloud-native Ecosystems Research Investment
PRESS RELEASE published on 06/10/2025 at 07:28, 5 months 24 days ago Fabasoft continues its path of sustainable growth in fiscal year 2024/2025 Fabasoft AG reports EUR 86.8 million in sales revenue for fiscal year 2024/2025, showcasing sustainable growth and investments in development and personnel Financial Results Research And Development Sustainable Growth Fabasoft AG Cloud-native Ecosystem
Published on 12/05/2025 at 02:35, 3 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 32 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 37 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 52 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 2 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
